Home

PAR-23-058 - NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 26

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations NOT-OD-23-166 OD , NCI , NIA , NIAMS , NICHD , NIDDK , NIMH , NIMHD , OBSSR , ODP , ORWH , THRO Aug 28, 2023 May 8, 2026 R21, R15, R01, R34, K25, K99/R00, K01, R03, P01, K08, K23
Notice of Special Interest (NOSI): Epidemiology and Prevention in Alcohol Research NOT-AA-23-018 NIAAA , NCI Aug 24, 2023 Sep 6, 2026 R03, R21, R01, UG3/UH3, R61/R33
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology NOT-CA-23-060 NCI Apr 17, 2023 Jan 8, 2026 R33, R21, U01, R61, R03
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan NOT-OD-22-178 ODP , NCI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO Jul 14, 2022 May 8, 2025 R21, R01, UG3/UH3, R61/R33, R34, R03
Notice of Special Interest (NOSI): Preventive Interventions to Address Cardiometabolic Risk Factors in Populations that Experience Health Disparities NOT-OD-22-154 ODP , NCI , NHLBI , NIAAA , NIAMS , NIDCR , NIEHS , NIMHD , NINDS , OBSSR , ORWH Jun 14, 2022 Oct 6, 2025 R01, R21, R34, R03, UG3/UH3
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan NOT-OD-22-106 ODP , NCI , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO May 12, 2022 May 8, 2025 R03, R01, R34, R21, UG3/UH3, R61/R33, 333
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 NCI May 5, 2022 Jul 5, 2027 K22, R01, K08, K01, R21, R03, K99/R00
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes NOT-CA-22-045 NCI Feb 3, 2022 Mar 1, 2024 P01, R21, R01, R03
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research NOT-CA-22-037 NCI , NHLBI , NIA , NIDA , NIMH , NINR , OBSSR Jan 27, 2022 Mar 9, 2024 R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors NOT-CA-22-029 NCI Jan 7, 2022 Oct 9, 2024 R01, R21, P01, R03
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects NOT-OD-22-023 ODP , NCI , NIDA , NIMHD , NIDCR Dec 8, 2021 May 9, 2024 R21, R01, 333, R34, R03, R61/R33
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-22-014 NCI Dec 8, 2021 Oct 9, 2024 R03, R01, R21, P01
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAID , NIAMS , NCCIH , NCI Nov 23, 2021 Jan 8, 2025 R03, R21, U01, U44, R01, R34, P01, R61/R33
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 NCI , NHLBI Nov 4, 2021 Nov 6, 2024 R01, R03, R21, P01
Notice of Special Interest (NOSI): Early-life Factors and Cancer Development Later in Life NOT-CA-21-074 NCI May 5, 2021 Mar 8, 2024 R01, R21, R03
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health NOT-OD-21-100 OBSSR , NIMHD , NIDA , NIMH , ORWH , NIDCD , SGMRO , ODP , NIA , NHLBI , NCI , NINR , NCCIH , NEI , NICHD Apr 8, 2021 Jun 8, 2024 R01, R21, R03, R41/R42, R43/R44, R21/R33, UG3/UH3, R34
Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being NOT-OD-21-087 ODP , NCCIH , NCI , NIA , NIAAA , NIAMS , NICHD , NIDCD , NIMH , NIMHD , NINR , OBSSR , ORWH Apr 6, 2021 Feb 16, 2024 R01, R21, 333, R03
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes NOT-CA-21-031 NCI , NIA Jan 27, 2021 Jan 8, 2024 R21, R03, R01, U01, P01, K99/R00, K08, R43/R44, R41/R42, R13, R21/R33, K01, K23
Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations NOT-HG-20-010 NHGRI , NCI , NHLBI Jan 13, 2020 Oct 5, 2023 R01, R21, R03

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-22-022 ODP NIDCR NCI NIEHS NIDA Dec 9, 2021 May 9, 2023 R01, R61/R33, R21, 333, R03
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology NOT-CA-22-003 NCI Nov 30, 2021 May 8, 2023 R03, R61, R33, R21
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-21-127 ODP NIEHS NIDCR NIDA NCI Jun 28, 2021 May 8, 2023 333, R03, R01, R21
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 NCI Apr 9, 2020 May 8, 2023 R03, R21, R01, P01
Notice of Special Interest: Alcohol and Cancer Control NOT-CA-20-034 NCI Mar 19, 2020 Sep 9, 2023 R01, R21, R03, 333
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026 NCI Feb 21, 2020 May 8, 2023 R01, R21, R03, P01
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 NCI Jan 15, 2020 Jan 8, 2023 R01, R21, R03


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health